-
[1]
Ke Wang, Yu Pan, Dianbing Wang, Ye Yuan, Min Li, Yuanyuan Chen, Lijun Bi, Xian-En Zhang, 2023: Altered hACE2 binding affinity and S1/S2 cleavage efficiency of SARS-CoV-2 spike protein mutants affect viral cell entry, Virologica Sinica, 38, 595-605. doi: 10.1016/j.virs.2023.06.005
-
[2]
Mengyuan Chen, Shuizhen He, Hualong Xiong, Dongxu Zhang, Shaojuan Wang, Wangheng Hou, Xiaomei Zhu, Jin Wang, Yang Huang, Congming Hong, Yubin Wu, Ruoyao Qi, Tianying Zhang, Quan Yuan, Tingdong Li, Yixin Chen, Shiyin Zhang, Shengxiang Ge, Jun Zhang, Ningshao Xia, 2022: New discovery of high-affinity SARS-CoV-2 spike S2 protein binding peptide selected by PhIP-Seq, Virologica Sinica, 37, 758-761. doi: 10.1016/j.virs.2022.07.001
-
[3]
Yuanyuan Qu, Xueyan Zhang, Meiyu Wang, Lina Sun, Yongzhong Jiang, Cheng Li, Wei Wu, Zhen Chen, Qiangling Yin, Xiaolin Jiang, Yang Liu, Chuan Li, Jiandong Li, Tianlei Ying, Dexin Li, Faxian Zhan, Youchun Wang, Wuxiang Guan, Shiwen Wang, Mifang Liang, 2021: Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants, Virologica Sinica, 36, 934-947. doi: 10.1007/s12250-021-00409-4
-
[4]
秦莉, 吴少庭, 王西明, 袁仕善, 黄达娜, 雷民军, 潘晖榕, 高世同, 张仁利, 屈伸, 2005: Purification of Glutathione S-transferase Fusion Proteins of SARS Coronavirus Spike Protein fragment 2 and Preparation of Anti-GST-S2 Polyclonal Antibody, Virologica Sinica, 20, 217-220.
-
[5]
王大燕, 王健伟*, 魏强, 屈建国, 洪涛, 2005: Purification of Glutathione S-transferase Fusion Proteins of SARS Coronavirus Spike Protein ragment 2 and Preparation of Anti-GST-S2 Polyclonal Antibody, Virologica Sinica, 20, 247-252.
-
[6]
Zherui Zhang, Hongqing Zhang, Yanan Zhang, Qiuyan Zhang, Qiaojie Liu, Yanyan Hu, Xiaoling Chen, Jing Wang, Yujia Shi, Chenglin Deng, Peng Gong, Bo Zhang, Xiaodan Li, Bing Zhu, Hanqing Ye, 2023: Oridonin inhibits SARS-CoV-2 replication by targeting viral proteinase and polymerase, Virologica Sinica, 38, 470-479. doi: 10.1016/j.virs.2023.04.008
-
[7]
Yuan Zhang, Chunjie Li, Xianliang Ke, Dan Luo, Yan Liu, Quanjiao Chen, Hanzhong Wang, Xiaohui Song, Zhenhua Zheng, 2022: Development of a biosensor assessing SARS-CoV-2 main protease proteolytic activity in living cells for antiviral drugs screening, Virologica Sinica, 37, 459-461. doi: 10.1016/j.virs.2022.04.002
-
[8]
Leike Zhang, Jia Liu, Ruiyuan Cao, Mingyue Xu, Yan Wu, Weijuan Shang, Xi Wang, Huanyu Zhang, Xiaming Jiang, Yuan Sun, Hengrui Hu, Yufeng Li, Gang Zou, Min Zhang, Lei Zhao, Wei Li, Xiaojia Guo, Xiaomei Zhuang, Xing-Lou Yang, Zheng-Li Shi, Fei Deng, Zhihong Hu, Gengfu Xiao, Manli Wang, Wu Zhong, 2020: Comparative Antiviral Efficacy of Viral Protease Inhibitors against the Novel SARS-CoV-2 In Vitro, Virologica Sinica, 35, 776-784. doi: 10.1007/s12250-020-00288-1
-
[9]
Jia Quan, Xiangjun Zhang, Yuanfu Ding, Shengke Li, Yang Qiu, Ruibing Wang, Xi Zhou, 2021: Cucurbit[7]uril as a Broad-Spectrum Antiviral Agent against Diverse RNA Viruses, Virologica Sinica, 36, 1165-1176. doi: 10.1007/s12250-021-00404-9
-
[10]
Anthony T. Tan, Joey Ming Er Lim, Antonio Bertoletti, 2022: Protection from infection or disease? Re-evaluating the broad immunogenicity of inactivated SARS-CoV-2 vaccines, Virologica Sinica, 37, 783-785. doi: 10.1016/j.virs.2022.11.002
-
[11]
Xiaorui Xing, Lei Wang, Zhen Cui, Wangjun Fu, Tao Zheng, Lili Qin, Pingju Ge, Aidong Qian, Nan Wang, Shuai Yuan, 2022: Structures of SARS-CoV-2 spike protein alert noteworthy sites for the potential approaching variants, Virologica Sinica, 37, 938-941. doi: 10.1016/j.virs.2022.11.003
-
[12]
Yabin Hu, Jun Chen, Jing Yang, Zhanpeng Liu, Xiaoyue Zhang, Qian Wu, Lulu Liu, Shishan Teng, Rongzhang He, Bo Liu, Xingyu Zheng, Rui Lu, Dong Pan, You Wang, Liting Peng, Hongying chen, Yi-Ping Li, Wenpei Liu, Xiaowang Qu, 2024: Isolation and characterization of spike S2-specific monoclonal antibodies with reactivity to pan-coronaviruses, Virologica Sinica, 39, 169-172. doi: 10.1016/j.virs.2023.10.008
-
[13]
Mingqing Lu, Kunpeng Liu, Yun Peng, Zhe Ding, Yingwen Li, Alexander Tendu, Xue Hu, Ge Gao, Weiwei Guo, Hang Liu, Juhong Rao, Jiaxuan Zhao, Miaoyu Chen, Zhiming Yuan, Gary Wong, Chao Shan, Yanfeng Yao, Jiaming Lan, 2022: Recombinant chimpanzee adenovirus vector vaccine expressing the spike protein provides effective and lasting protection against SARS-CoV-2 infection in mice, Virologica Sinica, 37, 581-590. doi: 10.1016/j.virs.2022.05.006
-
[14]
Yun-Yun Jin, Hanwen Lin, Liu Cao, Wei-Chen Wu, Yanxi Ji, Liubing Du, Yiling Jiang, Yanchun Xie, Kuijie Tong, Fan Xing, Fuxiang Zheng, Mang Shi, Ji-An Pan, Xiaoxue Peng, Deyin Guo, 2021: A Convenient and Biosafe Replicon with Accessory Genes of SARS-CoV-2 and Its Potential Application in Antiviral Drug Discovery, Virologica Sinica, 36, 913-923. doi: 10.1007/s12250-021-00385-9
-
[15]
Yu-xuan HOU, Cheng PENG, Zheng-gang HAN, Peng ZHOU, Ji-guo CHEN, Zheng-li SHI, 2010: Immunogenicity of the Spike Glycoprotein of Bat SARS-like Coronavirus, Virologica Sinica, 25, 36-44. doi: 10.1007/s12250-010-3096-2
-
[16]
Shichuan Wang, Mirko Trilling, Kathrin Sutter, Ulf Dittmer, Mengji Lu, Xin Zheng, Dongliang Yang, Jia Liu, 2020: A Crowned Killer's Résumé: Genome, Structure, Receptors, and Origin of SARS-CoV-2, Virologica Sinica, 35, 673-684. doi: 10.1007/s12250-020-00298-z
-
[17]
Yanling Huang, Hang Yang, Junping Yu, Hongping Wei, 2015: Molecular dissection of phage lysin PlySs2: integrity of the catalytic and cell wall binding domains is essential for its broad lytic activity, Virologica Sinica, 30, 45-51. doi: 10.1007/s12250-014-3535-6
-
[18]
Shi-Zhe Xie, Mei-Qin Liu, Ren-Di Jiang, Hao-Feng Lin, Wei Zhang, Bei Li, Jia Su, Fei Ke, Qi-Ya Zhang, Zheng-Li Shi, Xing-Lou Yang, 2022: Fish ACE2 is not susceptible to SARS-CoV-2, Virologica Sinica, 37, 142-144. doi: 10.1016/j.virs.2022.01.020
-
[19]
裘娟萍, 周宁一, 1995: A Broad spectrum Antiphage Strain Constituted with Protoplast Fusion Technology, Virologica Sinica, 10, 362-.
-
[20]
Hang Yang, Huijun Yuan, Xiaohui Zhao, Meng Xun, Shangrui Guo, Nan Wang, Bing Liu, Hongliang Wang, 2022: Cytoplasmic domain and enzymatic activity of ACE2 are not required for PI4KB dependent endocytosis entry of SARS-CoV-2 into host cells, Virologica Sinica, 37, 380-389. doi: 10.1016/j.virs.2022.03.003